Miniatura

Fitxers

COPD-428316-persistent-respiratory-failure-and-re-admission-in-patients-.pdf (1.43 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2023-11-01

Llicència de publicació

cc by-nc (c) Figueira Gonçalves, Juan Marco et al, 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/204326

Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.2147/COPD.S428316

Resum

Background: Chronic obstructive pulmonary disease (COPD) has been associated with worse clinical evolution/survival during a hospitalization for SARS-CoV2 (COVID-19). The objective of this study was to learn the situation of these patients at discharge as well as the risk of re-admission/mortality in the following 12 months.Methods: We carried out a subanalysis of the RECOVID registry. A multicenter, observational study that retrospectively collected data on severe acute COVID-19 episodes and follow-up visits for up to a year in survivors. The data collection protocol includes general demographic data, smoking, comorbidities, pharmacological treatment, infection severity, complications during hospitalization and required treatment. At discharge, resting oxygen saturation (SpO2), dyspnea according to the mMRC (modified Medical Research Council) scale and long-term oxygen therapy prescription were recorded. The follow-up database included the clinical management visits at 6 and 12 months, where re-admission and mortality were recorded.Results: A total of 2047 patients were included (5.6% had a COPD diagnosis). At discharge, patients with COPD had greater dyspnea and a greater need for prescription home oxygen. After adjusting for age, sex and Charlson comorbidity index, patients with COPD had a greater risk of hospital re-admission due to respiratory causes (HR 2.57 [1.35-4.89], p = 0.004), with no significant differences in survival.Conclusion: Patients with COPD who overcome a serious SARS-CoV2 infection show a worse clinical situation at discharge and a greater risk of re-admission for respiratory causes.

Matèries

COVID-19, Malalties pulmonars obstructives cròniques

Matèries (anglès)

COVID-19, Chronic obstructive pulmonary diseases

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

FIGUEIRA GONÇALVES, Juan marco, GARCÍA BELLO, Miguel ángel, RAMALLO FARIÑA, Yolanda, MÉNDEZ, Raúl, LATORRE CAMPOS, Ana, GONZÁLEZ JIMÉNEZ, Paula, PECES BARBA, Germán, MOLINA MOLINA, María, ESPAÑA, Pedro pablo, GARCÍA, Estela, DOMÍNGUEZ-PAZOS, Santiago de jorge, GARCÍA CLEMENTE, Marta, PANADERO, Carolina, ROSA CARRILLO, David de la, SIBILA, Oriol, MARTÍNEZ PITARCH, María dolores, TOLEDO PONS, Nuria, LÓPEZ RAMIREZ, Cecilia, ALMONTE BATISTA, Wanda, MACÍAS PAREDES, Abigail, BADENES BONET, Diana, PÉREZ RODAS, Eli nancy, LÁZARO, Javier, QUIRÓS FERNÁNDEZ, Sarai, CORDOVILLA, Rosa, CANO PUMAREGA, Irene, TORRES MARTÍ, Antoni, MENÉNDEZ, Rosario, RECOVID. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19. _International Journal of Chronic Obstructive Pulmonary Disease_. 2023. Vol. 18, núm. 2473-2481. [consulta: 21 de gener de 2026]. ISSN: 1178-2005. [Disponible a: https://hdl.handle.net/2445/204326]

Exportar metadades

JSON - METS

Compartir registre